![Cecilia Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cecilia Jones
Financieel Directeur/CFO bij
AGIOS PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 31-05-2026
Profiel
Cecilia Jones is currently Chief Financial Officer at Agios Pharmaceuticals, Inc. since 2022.
Formerly, Ms. Jones was Treasurer, Chief Financial & Accounting Officer at LogicBio Therapeutics, Inc. from 2021 to 2022, Senior Director-Corporate Finance at Biogen, Inc. from 2015 to 2019, and Director-International Finance at Genzyme Corp.
from 2003 to 2009.
Ms. Jones completed undergraduate studies at the University of San Andres and earned an MBA from Harvard Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-04-2026 | 54.998 ( 0,09% ) | 2 M $ | 31-05-2026 |
Actieve functies van Cecilia Jones
| Bedrijven | Functie | Begin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 26-09-2022 |
Eerdere bekende functies van Cecilia Jones
| Bedrijven | Functie | Einde |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Financieel Directeur/CFO | 23-09-2022 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01-11-2009 |
| BIOGEN INC. | Corporate Officer/Principal | - |
Opleiding van Cecilia Jones
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
71
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
University of San Andres
 University of San Andres Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
